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Department of Pharmacology, Lafayette Clinic, Detroit, Michigan 48207, USA and The University of Michigan, 
Ann Arbor, Michigan 48109, USA 
The free urinary metabolites, homovanillic, indoleacetic and 5-hydroxyindoleacetic acid were measured in 24 h 
urines obtained from seven highly selected drug-free chronic schizophrenic patients and seven mentally normal 
control subjects on a low arnine diet. Gas chromatography selected ion monitoring of silylated extracts was used 
to assay each metabolite using its own deuterated form as an internal standard. In the electron impact mode the 
positive ion fragments used to quantitate the amount of each metabolite in the urine were, respectively, m/z  
209/211 for homovanillic acid, 319/321 for indoleacetic acid and 290/292 for 5-hydroxyindoleacetic acid. It was 
found essential that each compound be assayed using its own deuterated derivative as the internal standard. 
When expressed per mg creatinine, the homovanillic and 5-hydroxyindoleacetic acid levels of the chronic 
schizophrenic patients were in the normal range, but indoleacetic acid was slightly and statistically significantly 
higher, p = 0.01. 
INTRODUCTION 
Urinary levels of neurotransmitter metabolites other 
than 4-hydroxy-3-rnethoxyphenylethyl glycol (HMPG) 
do not reflect brain metabolism.' Nevertheless, some 
theories of schizophrenia suggest a gross abnormality in 
either dopamine or serotonin (5 -hydroxyindolethyl- 
amine, 5-HT) metabolism which may be reflected in the 
Numerous investigators have reported either 
an increase, decrease, or no change in each of these 
neurotransmitter metabolites in various schizophrenic 
patient populations. However, the patients studied were 
heterogenous, drug intake and diet not controlled, and 
relatively nonspecific chemical assays were ~ s e d . ~ - ~  
The present research deals with a small group of 
highly selected, drug-free schizophrenic patients and 
normal subjects on a low amine diet in which urinary 
homovanillic acid (HVA), indoleacetic acid (IAA) and 
5-hydroxyindoleacetic acid (5-HIAA) were assayed 
using gas chromatography and selected positive ion 
monitoring. 
EXPERIMENTAL 
Subjects 
Seven normal male volunteers and seven male drug-free 
chronic schizophrenic patients were studied. No 
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significant differences were found between the two 
groups in age or height. However, the patients' mean 
weight was 66.4 kg, while the controls' mean weight was 
84.7 kg, ( p  < 0.025). The controls were all drug-free, 
Lafayette Clinic personnel. The patients had all been 
mentally ill since adolescence or early adulthood. No 
significant therapeutic benefits were derived from 
neuroleptic medication, so all drug administration had 
been discontinued for at least two years to avoid the risk 
of tardive dyskinesia. 
The research protocol was approved by the Lafayette 
Clinic Institutional Review Board and the Technical 
Advisory Committee on Research of the Michigan 
Department of Mental Health. 
Diet 
The subjects were on a low amine diet"." and did not 
eat pineapples, walnuts, broadbeans, bananas, eggplant, 
tomatoes, tomato products, or 'aged' cheeses for one 
week before the collection. Alcohol was not permitted 
for three days before the collection period. These 
restrictions also applied during the 24 h of the collection. 
The patients were all given a vitamin supplement. 
The urine was collected in plastic containers and kept 
at either 4 "C or -20 "C during the collection period. At 
the end of the collection period, the urines were stored at 
-80 "C until analysis. 
Chemical assays 
Urine creatinine was determined by a modification of 
the JaffC reactionI2 as well as a new high performance 
liquid chromatographic assay developed by Buchanan 
et al.13 HVA, IAA, 5-HIAA were extracted by a 
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I 
Rinse precipitate twice with 
I rnl 0.1 M Ba (OH), 
centrifuge as before 
modification of the anion exchange method of Jaakon- 
maki et al.14 and further developed by other investiga- 
t o r ~ . ' ' ~ ' ~  Our procedure closely follows that of Gates 
et The overall scheme is summarized in Fig. 1. The 
internal standard for IAA, 5-HIAA and HVA was the 
a-['H2] analog (Merck & Co., Inc., Rahway, New 
Jersey). A urine volume corresponding to 1.5 mg of 
creatinine was used for analysis. This was added to a 
tube containing 8 pg of each internal standard 
evaporated from a stock methanol solution. The urine 
was then treated with 3 ml of 0.1 M barium hydroxide 
and centrifuged to precipitate phosphate and sulfate as 
the barium salts. The precipitate was washed with 2 x 
1 ml barium hydroxide and the solutions combined. 
Acetic acid was then used to neutralize the supernatants 
to a pH 7-8. This avoided the formation of excess 
pyridium hydrochloride in the final product. The organic 
acids were then isolated on a DEAE Sephadex column 
of 1 cm diameter filled to a height of 8 cm (A-25-120 
DEAE Sephadex, Sigma Chemical Co., St Louis, 
Missouri). 
The Sephadex was previously treated with 1.0 M 
pyridium acetate for 48 h and a final equilibration 
at 0.5 M pyridium acetate for another 24 h. Several 
changes of each wash were made. Before use, the 
columns were rinsed with 20 ml of 0.5 M pyridium 
acetate. After the urine flowed through, the columns 
were rinsed with 50 ml of distilled water. The isolated 
acid fraction of urine was then eluted from the columns 
with 40 ml of 1.5 M pyridium acetate. This solution was 
then freeze dried. The residue was derivatized with 
130 p.1 of bis-(trimethylsily1)trifluoroacetamide (Pierce) 
and 30 pI dimethylformamide as a catalyst, by heating 
for 30 min at 80 "C to form the trimethylsilyl derivatives. 
Immediately after derivatization, the solution was 
transferred to glass capillary tubes and flame sealed. The 
tubes were then stored at 4 °C  until analyzed by 
GCMS. All glass containers were silated before use with 
5 %  dimethyldichlorosilane in toluene. Due to the light 
sensitivity of 5-HIAA, the columns and freeze dry flasks 
were shielded with aluminum foil.I8 
A Finnigan 3200 quadrapole gas chromatograph mass 
spectrometer with a 6100 data system was used in this 
study. GC conditions were with a helium carrier flow 
of about 20 ml min-', injection port temperature of 
250 "C, and glass jet separator temperature at 220 "C. 
A 3% OV 225 on 100/120 Gas Chrom Q (Applied 
Science) column, 5 ft X 2 mm i.d. was used. 
The mass spectrometer was operated at 70 eV in the 
electron impact mode. Mass fragmentography of HVA 
was done isothermally with the GC column at 170 "C. 
IAA and 5-HIAA were analyzed on a single GC run 
with data system control and change over for the proper 
ion fragments to be monitored. These were run with the 
G C  column at 190°C. Standard curves of each 
compound were prepared by spiking urine with increas- 
ing amounts of each compound. 
RESULTS 
The mass spectra of all three derivatized compounds and 
their deuterated analogs show characteristic frag- 
mentation patterns (see Figs. 2-4) corresponding to 
Internal standard in methanol (200 ng PI-') added to 
12 ml centrifuge tube 
Methanol evaporated under N2 
1.5 mg creatinine equivalent of 
urine added 
Soni cate 
Add 3 ml 0.1 M Ba (OH}, and vortex briefly 
Centrifuge for 2 0 s  at top speed 
in a bench top centrifuge 
1 
Effluent discarded 
I 
Column rinsed with 50 ml 
distilled water 
Effluent -containing Organic acids on 
the column eluted 
with 40 ml 1.5 M 
pyridium acetate 
Sephadex column 
neutral and basic 
compounds discarded 
1 
I 5  M pyridium ice late  collected in 
250 ml freeze dry flasks, freeze discarded 
dried to volume of 5-10 ml, and 
transferred to 40 ml centrifuge tubes 
Freeze dry overnight 
To each tube add 130 pI BSTFA 
and 3 0 ~ 1  DMF, heat at 80 OC 
for 20 min, mixing to dissolve 
I 
GCMS analysis 
Figure 1. Method of extract ing and der ivat iz ing organic  urine acid  
metabol i tes .  T h i s  i s  a g e n e r a l  method w h i c h  is  useful  for  al l  
organic  ac ids in the ur ine,  n o t  o n l y  t h o s e  studied here in .  Especi- 
a l ly  i m p o r t a n t  is  the u s e  of a stable  i s o t o p e  der ivat ive  of HVA, 
5-HIAA a n d  especial ly IAA for quant i ta t ive  a n d  l inear recoveries. 
a-cleavage as shown even with different  derivative^.'^.'^ 
For each compound and its deuterated internal stan- 
dard, the most prominent ion pair consistent with good 
selectivity from interfering peaks was used for 
quantification. Since in our Finnigan data system four 
ions could be monitored simultaneously in the selected 
ion monitoring mode, two other ions were monitored for 
each compound to insure specificity. 
For HVA and a-[*H2]HVA, these ions were mlz  209 
and 21 1 for quantification and the molecular ions at m l z  
326 and 328 were monitored to confirm.the identity of 
HVA. For IAA and [*H2]IAA the prominent ions mlz  
202 and 204 showed minor interferences so 
quantification was done on the molecular ions 319 and 
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Figure2. Mass spectra of hornovanillic acid (a) and its a-deu- 
terated trimethylsilyl derivative (b). The ion at mlz 209 and the 
molecular ion at mlz 326for HVA, and the corresponding ions at 
mlz 21 1 and 328 for a-[*H2]-HVA TMS were monitored for posi- 
tive identification. 
321. For 5-HIAA and r2H2]-5-HIAA interferences 
were sometimes noted at the molecular ions at mlz 407 
and 409, so quantification was done at m l z  290 relative 
to 292. 
We experienced great difficulty in obtaining complete 
24 h urine collections from our very ill, nonmedicated 
patients. We have included in our data only the urine 
collections which had a creatinine value of at least 
14.0mgkg-' 24 h-' and with a pH of 5.0-6.5. Using 
these criteria, we kept one to three collections from each 
subject and averaged each individual's results. The 24 h 
urinary volumes were still significantly lower ( p  < 
0.005), so we based our values on mg creatinine 
excreted. 
c OI
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Figure3. Mass spectra of indoleacetic acid (a) and its a-deu- 
terated trirnethylsilyl derivative (b). The ion at m/z 202 and the 
molecular ion at mlz 319 for IAA, and the corresponding ions at 
mlz 204 and 321 for a-['H2]-IAATMS were monitored for positive 
identification. 
Urinary 5-HIAA, IAA and HVA levels were within 
normal l i r n i t ~ ' ~ , ~ ~ - ~ '  summarized in Table 1. The patient 
IAA values were greater than those of the normal 
control subjects and were statistically significant ( p  = 
0.01). Both HVA and 5-HIAA urinary levels were not 
significantly different from those of the controls. 
DISCUSSION 
The disadvantage of the present assay is the length of 
time required to prepare samples prior to analysis. This 
is due to the preparation and column separation- 
approximately one working day-and the time required 
for freeze drying-about 24 h for 14 samples in our 
freeze drier (Virtis Model 10-010). The advantages are 
stability of the final samples and ease of applicability to 
~~ ~ ~ 
Table 1. Comparison of 24 hour urinary levels of homovanillic, indoleacetic and 5-hydroxyindoleacetic acid levels in drug-free 
chronic schizophrenic patients and mentally normal control subjects" 
Controls 
1 
2 
3 
4 
5 
6 
7 
Mean f SE 
Patients 
1 
2 
3 
4 
5 
6 
7 
Mean * SE 
Body 
Weight surface 24 h Creatinine 
( k d  area volume (ml) (mg kg-'I 
71.4 
85.5 
92.3 
78.2 
83.25 
94.5 
84.7 i 3.0 
87.75 
70.9 
63.6 
49.5 
65.5 
59.1 
100.0 
56.2 
66.4* 6.2 
1.92 
2.01 
2.12 
2.02 
2.00 
2.12 
2.20 
2.06+ .04 
1.87 
1.81 
1.57 
1.81 
1.73 
2.28 
1.75 
1.83 f .08 
1381 
1320 
1633 
1577 
1340 
1150 
1000 
1343 f 84 
500 
1185 
345 
81 9 
902 
1150 
351 
750k 135 
20.31 8.23 
21.31 6.22 
20.2 5.06 
21.78 6.23 
28.17 4.72 
21.1 5.23 
33.65 3.60 
23.8+ 1.9 5.61 10.55 
14.53 5.00 
25.3 2.98 
19.93 5.40 
22.5 5.05 
16.3 4.38 
14.49 5.03 
17.17 5.01 
18.6*1.6 4.69k0.31 
Probability 0.021 0.029 0.0028 0.060 0.172 
a C = creatinine. Student 't' test group comparison, two-tailed estimates of probability. 
IW-1 c1 
(1.9 mg 
8.61 
6.96 
8.57 
7.60 
5.47 
6.48 
5.64 
7.05+0.48 
8.72 
7.93 
7.44 
9.78 
10.4 
10.0 
8.68 
8.99 0.42 
0.010 
5-HIAA 
(la mg-' C) 
5.39 
4.40 
5.64 
3.94 
6.03 
3.88 
4.84 
4.87 * 0.32 
5.49 
4.16 
5.55 
5.45 
6.9 
4.67 
5.29 
5.36* 0.32 
0.306 
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Figure 4. Mass spectra of 5-hydroxyindoleacetic acid (a) and its 
a-deuterated trimethylsilyl derivative (b). The ion at rnlz 290 and 
the molecular ion at rnlz 407 for 5-HIAA, and the corresponding 
ion at rnlz 292 and 409 for C X - [ ~ H ~ ] - ~ - H I A A  TMS were monitored 
for positive identification. 
other organic acids. Hence, the assay is used primarily as 
a procedure for profiling all urine organic acids where it 
is essential to extract all acidic compounds equivalently. 
As such, this assay would be readily adaptable to any 
other organic acids of interest. 
When stored in an ordinary refrigerator (+4 "C) we 
detected no deterioration of the derivatized samples for 
as long as a year. It must be noted, though, that the use of 
deuterated internal standards would mask minor 
deterioration of a compound. This stability is a definite 
advantage in laboratories with user shared GCMS 
systems, where equipment access might be delayed. 
The precision of this assay, when the corresponding 
deuterated acid is used as the internal standard, is 
satisfactory. Duplicate samples assayed independently 
were within 10% of each other. This was not the case 
when [2H2]-5-HIAA was used as the internal standard 
for IAA in particular. It should also be point7d out that 
there is a problem of cross-talk between the H and 2H 
compounds. There is a slight but real contribution of the 
deuterated internal standard to the masses monitored 
for the naturally occurring metabolites and vice versa. 
This varies with the specific compounds and their rela- 
tive abundance. If the ratio of the stable isotope and 
naturally occurring species is within relatively narrow 
limits, the standard curve is linear. This is not true at the 
extremes. Although these relative contributions can be 
calculated, we derived standard curves and used the 
linear segments for our analyses. 
It should be emphasized that the schizophrenic 
patients used in this study were highly selected as having 
chronic process schizophrenia, unresponsive to current 
antidopamine medication. Presumably they represent a 
subgroup of schizophrenics whose illness does not 
include a disturbance of dopamine metabolism. Urinary 
levels of HVA, the metabolite of dopamine, were 
normal. Although 5-HIAA levels tended to be slightly 
higher in these patients, the differences were not statis- 
tically significant. However, the elevated IAA urinary 
levels were significant even in this small sample size. 
It should be noted that we measured only free levels of 
these organic acids. Further studies are needed to 
measure the relative amounts of free vs conjugated acid 
metabolites. 
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